EksoNR is the latest-generation device of the most clinically used robotic exoskeleton on the market. It was previously cleared by the FDA for stroke and spinal cord injury rehabilitation in 2016 and
critically contributes to the diagnosis and therapy of diseases such as multiple sclerosis and brain tumors but also rare disorders hard to diagnose,...functions. Today, roughly 25% of patients with multiple sclerosis and 50% of patients with brain tumors are diagnosed based on neuro-ophthalmic symptoms.
between the primary motor cortex and a muscle to assess damage in patients with neurological diseases and conditions such as stroke, multiple sclerosis, amyotrophic...lateral sclerosis, movement disorders, motor neuron disease, migraine, and other injuries and disorders affecting the facial and cranial nerves and spinal
for clinical diagnoses and research, including neurodegenerative diseases, multiple sclerosis, metabolic disorders, and pediatric brain disorders. However,
to increase the performance of the patients after brain injuries, stroke, multiple sclerosis, Parkinson’s disease and muscle dysfunction.
tense recovery rehabilitation to prevent sarcopenia, improve diabetes or decrease risk of multiple sclerosis. ● Orthopedic heel supportive pedal
Recumbent stepper training is safe and comfortable, reduced fatigue, and in progressive Multiple Sclerosis. ● For focused rehabilitation, the user can
help patients restore hand function if their condition is due to any of the following central nervous system pathologies: Stroke (CVA) Multiple Sclerosis
is suitable for patients with dorsiflexor weakness and spasticity due to any of the following central nervous system pathologies: Stroke (CVA) Multiple...Sclerosis (MS) Cerebral Palsy (CP) Traumatic Brain Injury (TBI) Incomplete Spinal Cord Injury Certain neurological disorders
21 Sep 2022 | in our understanding are holding back therapeutic development in areas such as Alzheimer’s, Parkinson’s, Huntington’s disease, multiple sclerosis,
and was the first robotic exoskeleton to be granted clearance for use with Stroke, Brain Injury, Spinal Cord Injury, and Multiple Sclerosis. This broad clearance
for rehabilitation of people with diseases or injuries in the nervous system, such as stroke, spinal cord injury, cerebral palsy or multiple sclerosis, among others.
with a variety cause of disease such as stroke, SCI（spinal cord injury）, brain tumors, multiple sclerosis, cerebral palsy, and other diseases related
impairments such as spinal cord injury, stroke, multiple sclerosis, Parkinson’s, brain injury, transverse myelitis, or cerebral palsy.
system disorders such as multiple sclerosis (MS), stroke (CVA), spinal cord injury, or cerebral palsy (CP) among others. In 2017, NerveAide was founded
To use the full function of this web site, JavaScript needs to be enabled in your browser.
This is how you enable JavaScript in your browser settings: Read instruction
